This two-part series will review innovative sustained-delivery options in the retina space for both long- and short-term indications.
In part 1, I discuss implants designed to treat chronic inflammation. Part 2 will cover postoperative sustained-release steroids.
Diseases of the choroid and retina are diverse in their underlying pathology, patient profiles and treatments. In many cases, underlying disease processes necessitate long-term, repeated treatment. Fortunately, we have seen recent innovations designed to meet this challenge, with sustained-release corticosteroids available for